Fig. 3From: 18F-fluoride-PET for dynamic in vivo monitoring of bone formation in multiple myeloma 18F-uptake before and after bortezomib treatment. 18F-uptake per lesion is shown before and after treatment. It is shown that 18F-uptake differs between and within patients. In addition, there is a large inter- and intra-individual heterogeneityBack to article page